JP2011121949A5 - - Google Patents

Download PDF

Info

Publication number
JP2011121949A5
JP2011121949A5 JP2010278550A JP2010278550A JP2011121949A5 JP 2011121949 A5 JP2011121949 A5 JP 2011121949A5 JP 2010278550 A JP2010278550 A JP 2010278550A JP 2010278550 A JP2010278550 A JP 2010278550A JP 2011121949 A5 JP2011121949 A5 JP 2011121949A5
Authority
JP
Japan
Prior art keywords
sod1
ips cell
cell
test compound
ips
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010278550A
Other languages
English (en)
Other versions
JP2011121949A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011121949A publication Critical patent/JP2011121949A/ja
Publication of JP2011121949A5 publication Critical patent/JP2011121949A5/ja
Pending legal-status Critical Current

Links

Claims (5)

  1. 筋萎縮性側索硬化症の予防および治療薬をスクリーニングする方法であって、以下の工
    程を含む方法;
    (1)SOD1に変異を有するiPS細胞から分化誘導された神経系細胞と試験化合物を接触させる工程、
    (2)該神経系細胞のSOD1の発現量を測定する工程、および
    (3)試験化合物と接触させなかった対照と比較して、該SOD1の発現量を減少させる試験化合物を選択する工程。
  2. 前記のiPS細胞が、筋萎縮性側索硬化症の患者由来のiPS細胞である、請求項に記載のスクリーニング方法。
  3. 前記のiPS細胞が、SOD1の106番目のロイシンに変異を有するiPS細胞である、請求項に記載のスクリーニング方法。
  4. 前記の神経系細胞が、アストロサイトである、請求項に記載のスクリーニング方法。
  5. 前記のアストロサイトが、以下の工程を含む方法で分化誘導された、請求項4に記載の方法;
    (1)iPS細胞からニューロスフェアを形成する工程、および
    (2)前記ニューロスフェアをLIFとBMPを含有する培地で培養する工程。
JP2010278550A 2009-12-14 2010-12-14 筋萎縮性側索硬化症の予防および治療用医薬組成物 Pending JP2011121949A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28613409P 2009-12-14 2009-12-14
US61/286,134 2009-12-14

Publications (2)

Publication Number Publication Date
JP2011121949A JP2011121949A (ja) 2011-06-23
JP2011121949A5 true JP2011121949A5 (ja) 2014-02-06

Family

ID=44167440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010278550A Pending JP2011121949A (ja) 2009-12-14 2010-12-14 筋萎縮性側索硬化症の予防および治療用医薬組成物

Country Status (4)

Country Link
US (1) US20130115622A1 (ja)
EP (1) EP2512514B1 (ja)
JP (1) JP2011121949A (ja)
WO (1) WO2011074690A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2641086B9 (en) 2010-11-18 2017-08-16 Kyoto University Method for screening drugs for suppressing inflammasome activity
JP6335117B2 (ja) * 2012-03-21 2018-05-30 国立大学法人京都大学 アルツハイマー病の治療薬および/または予防薬のスクリーニング方法
WO2014020933A1 (ja) * 2012-07-31 2014-02-06 アルバイオ株式会社 新規蛍光物質
WO2014104409A1 (en) * 2012-12-28 2014-07-03 Kyoto University Method for inducing astrocytes
SG11201507829SA (en) 2013-03-21 2015-12-30 Univ Kyoto Pluripotent stem cell for neuronal differentiation induction
JP6856266B2 (ja) * 2013-12-02 2021-04-07 国立大学法人京都大学 Fgfr3病の予防および治療剤ならびにそのスクリーニング方法
WO2016114322A1 (ja) 2015-01-13 2016-07-21 国立大学法人京都大学 筋萎縮性側索硬化症の予防及び/又は治療剤
KR20180055901A (ko) 2015-10-05 2018-05-25 오리그3엔, 인코포레이티드 간 기능장애의 확인 및 개선에 기반한 파킨슨병의 진단 및 치료
CN108624560B (zh) * 2018-06-01 2022-04-08 南京艾尔普再生医学科技有限公司 一种分化培养基及少突胶质前体细胞的制备方法
CN113842449B (zh) * 2021-09-08 2024-02-23 乐卫东 枸杞糖肽在制备预防和/或治疗肌萎缩侧索硬化的药物中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
ZA81703B (en) 1980-02-04 1982-09-29 Merck & Co Inc New antihypercholesterolemic compounds,intermediates and processes
JPS572240A (en) 1980-06-06 1982-01-07 Sankyo Co Ltd Ml-236b derivative
MX7065E (es) 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
US4739073A (en) 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
JPS60500015A (ja) 1982-11-22 1985-01-10 サンド・アクチエンゲゼルシヤフト メバロラクトン同族体とその誘導体、これらの製造法およびこれらを含有する製薬学的組成物
US5854259A (en) 1987-08-20 1998-12-29 Nissan Chemical Industries Ltd. Quinoline type mevalonolactones
JP2569746B2 (ja) 1987-08-20 1997-01-08 日産化学工業株式会社 キノリン系メバロノラクトン類
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
FR2688138B1 (fr) 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US7011828B2 (en) 2000-03-14 2006-03-14 Es Cell International Pte. Ltd. Implanting neural progenitor cells derived for human embryonic stem cells
EP1302533A4 (en) 2000-05-16 2004-11-17 Kyowa Hakko Kogyo Kk NEW METHOD FOR INDUCING DIFFERENTIATION OF EMBRYONIC STEM CELLS IN EECTODERMAL CELLS AND THEIR USE
CA2467258A1 (en) 2001-11-15 2003-05-22 Kyowa Hakko Kogyo Co., Ltd. Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same and use of the same.
WO2004000313A2 (fr) * 2002-06-24 2003-12-31 Exonhit Therapeutics Sa Traitement de la sclerose laterale amyotrophique avec des composes modulateurs de l’activite de pgc-1
US20050202488A1 (en) * 2004-03-02 2005-09-15 The General Hospital Corporation Assay for therapies that inhibit expression of the cytosolic Cu/Zn superoxide dismutase (SOD1) gene
JP5141016B2 (ja) 2004-06-18 2013-02-13 独立行政法人理化学研究所 無血清浮遊培養による胚性幹細胞の神経分化誘導法
EP1871359A1 (en) * 2005-04-07 2008-01-02 Miso Sabovic Delaying the ageing process and disorders caused by ageing
US20060252775A1 (en) * 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
EP3418297B1 (en) 2005-12-13 2023-04-05 Kyoto University Nuclear reprogramming factor
AU2007219615B2 (en) * 2006-03-03 2013-11-28 Promis Neurosciences Inc. Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
CA2684242C (en) 2007-03-23 2019-11-12 Wisconsin Alumni Research Foundation Somatic cell reprogramming
WO2008127974A1 (en) * 2007-04-13 2008-10-23 The Trustees Of Columbia University In The City Of New York Stem cell-based culture system for drug development
JP2009215191A (ja) * 2008-03-07 2009-09-24 Keio Gijuku 神経損傷治療剤及び神経損傷治療方法
WO2009146098A2 (en) * 2008-04-02 2009-12-03 President And Fellows Of Harvard College Stem cells and uses thereof

Similar Documents

Publication Publication Date Title
JP2011121949A5 (ja)
WO2012092364A3 (en) Method for sympathetic rebalancing of patient
JP2012518389A5 (ja)
WO2013052915A3 (en) Method for detecting replication or colonization of a biological therapeutic
WO2012019017A3 (en) Electrostatic chuck and methods of use thereof
JP2011080061A5 (ja)
BR112014007469A2 (pt) arcabouços de proteína com base em repetição de fibronectina tipo iii com superfícies de ligação alternativas
JP2008522001A5 (ja)
WO2011085075A3 (en) Assembly of high fidelity polynucleotides
JP2011099100A5 (ja)
GB2514970A (en) Enhanced storage of metadata utilizing improved error detection and correction in computer memory
JP2007532632A5 (ja)
JP2011525899A5 (ja)
JP2012166347A5 (ja)
FR2991076B1 (fr) Procede de traitement d'un ensemble de quadruplets de valeurs relatifs a des points de fonctionnement d'un accumulateur electrochimique, procede de determination d'un etat d'energie a partir des donnees issues du procede de traitement, support d'enregistrement, programme informatique et dispositif
FR2969762B1 (fr) Sonde de microscope a force atomique, son procede de preparation et ses utilisations
WO2012002662A3 (ko) 편광자의 제조방법
JP2010166901A5 (ja)
JP2009523791A5 (ja)
BR112016028185A2 (pt) método para produzir um l-aminoácido.
CN104535568A (zh) 一种生物比色传感器,其制备方法以及用途
JP2011530484A5 (ja)
WO2015040497A3 (en) Methods for nuclear reprogramming of cells
JP2011505864A5 (ja)
JP2011198549A5 (ja)